A judge’s ruling puts access to the abortion drug mifepristone in limbo, pending further court decisions. But there’s another drug that is safe and effective at ending early pregnancy.
NPR’s Scott Simon speaks to Kaiser Health News reporter Markian Hawryluk about a new report detailing how even telemedicine appointments can subject patients to exorbitant “facility fees.”
NPR’s Scott Simon speaks to Kaiser Health News reporter Markian Hawryluk about a new report detailing how even telemedicine appointments can subject patients to exorbitant “facility fees.”
Since the U.S. Supreme Court overturned Roe v. Wade, medical providers are encountering more legal and political battles — and escalating threats from the anti-abortion movement.
NPR’s Mary Louise Kelly asks OB-GYN Kristin Lyerly what doctors and patients in Wisconsin have been dealing with before the Supreme Court election — and how it affects abortion in the region.
When she gave birth to her baby with a fatal condition two months early, Samantha Casiano scrambled to raise funds for the funeral. Anti-abortion advocates say Texas laws are “working as designed.”
Some consumers who bought health insurance plans under the Affordable Care Act have had a tough start to the year: Many say it’s hard to find an in-network doctor or hospital.
So much in Wisconsin could depend on a single seat on the state Supreme Court. Tuesday’s winner will determine the court’s sway and could change the state’s abortion rights and redistricting.
The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.